It was reported recently that French drug manufacturer HRA Pharma had found that the emergency contraceptive Norlevo, which has a similar chemical makeup to Plan B One-Step, is ineffective for women over 176 pounds. Here’s why I was not surprised.
Right to Life of Michigan’s federal lawsuit adds to a pile of recent court cases challenging whether corporations can refuse to provide employees contraception coverage in employer-sponsored health insurance plans on moral grounds.
A “roving band of feminists” took to the streets, or rather the aisles, in New York City Saturday to protest pharmacies that restrict over-the-counter access to Plan B.
The shame and stigma around emergency contraception, and all reproductive health care for that matter, all too often deter those who need reproductive care the most from accessing it.
August 1 is the one-year anniversary of the Affordable Care Act regulation requiring no cost-coverage of women’s preventive services—including contraception—going into effect. Now we can also celebrate the fact that Plan B One-Step is finally on store shelves across the country.
Public health advocates are celebrating Monday night’s announcement that the Obama administration will comply with a court order to make emergency contraception available over-the-counter without age restrictions.
Why would the Obama administration support such restrictions, which not only put the health and lives of young women at risk, but also further disable young women from taking control of our sexuality?
The debate is characterized by anti-abortion anxiety and aversion to subsidized contraception.
Once again, politics have trumped science, and it’s women and girls who pay the price.
Inaccurate arguments posed by anti-choicers against emergency contraception are not about the health and safety of women and girls: Rather, their claims about EC’s safety are proxies for moral disapproval of sex.